Posts by: Joana Carvalho, PhD

Joana Carvalho, PhD

Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that made up the lining of blood vessels — found in the umbilical cord of newborns.

November 9, 2020November 9, 2020

IBD Charitable Foundation Announces 2020 Sherman Prize Winners

News

Two college professors — one from the University of Pennsylvania and the other from University of Chicago Medicine — have been named the winners of the 2020 Sherman Prizes, ... Read more

September 21, 2020September 21, 2020

ABX464 Effective at Keeping UC Patients in Remission Over Time, Data Show

News, Ulcerative colitis

ABX464, Abivax’s treatment candidate for ulcerative colitis (UC), continues to be safe and effective over time at keeping patients with moderate-to-severe UC in clinical remission, according to two-year data from ... Read more

July 27, 2020July 27, 2020

Flavonoids Found in Corn Reduce Bowel Inflammation in IBD Mouse Model

News

Scientists have discovered that certain flavonoids — natural compounds in fruits and vegetables that are known for their health benefits — found in corn plants have strong anti-inflammatory properties ... Read more

July 20, 2020July 20, 2020

Poor Oral Health May Worsen IBD Symptoms, Study Finds

News

Inflammatory conditions linked to poor oral health, such as severe gum infections, may worsen inflammatory bowel disease (IBD) by increasing the number of bacteria and immune cells causing gut ... Read more

June 15, 2020June 15, 2020

Scientists Find Variation in JAK2 Gene That Can Lead to IBD

News

Scientists have discovered a genetic variation in the janus kinase 2 (JAK2) gene — a gene involved in a signaling pathway implicated in other autoimmune diseases — that can ... Read more

April 6, 2020April 6, 2020

Scientists Identify Biomarkers, Environmental Factors That May Lead to IBD Prevention

News

Researchers at Mount Sinai have identified new protein biomarkers of Crohn’s disease, and environmental factors that may increase a person’s risk of developing inflammatory bowel disease (IBD). Together, these ... Read more

January 29, 2020January 29, 2020

Bile Acids Control Differentiation, Activity of Immune Cells that Play Key Role in IBD, Mouse Studies Find

News

Bile acids — acidic liquids produced by the liver and gallbladder to help the body digest food fats — promote the differentiation and activity of different types of immune ... Read more

January 22, 2020January 22, 2020

Phase 2 Trial of Oral Treatment for Ulcerative Colitis Expanding to US, Abivax Says

News

The U.S. Food and Drug Administration (FDA) has approved an investigational new drug (IND) application for ABX464, Abivax’s treatment candidate for ulcerative colitis (UC), allowing the company to expand its ... Read more

January 6, 2020January 7, 2020

UK Regulatory Agency Approves Launch of Innovation’s Phase 1 Trial of Brilacidin for Ulcerative Colitis

News

The United Kingdom’s Medicines and Healthcare products Regulatory Agency has approved the launch of Innovation Pharmaceuticals’ Phase 1 trial in healthy volunteers to investigate the safety and properties of ... Read more

December 16, 2019December 16, 2019

FDA Approves Avsola, Remicade Biosimilar, to Treat Crohn’s Disease and Ulcerative Colitis

News

The U.S. Food and Drug Administration (FDA) has approved Amgen’s Avsola (infliximab-axxq) — a biosimilar to Janssen’s Remicade (infliximab) — to treat adults and children with moderate-to-severe Crohn’s disease ... Read more